Krishicon Pharmaceuticals Private Limited
About Krishicon Pharmaceuticals Private Limited
Data last updated:
Krishicon Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2021PTC352896.
The company has an authorised share capital of ₹3.75 Lakh and a paid-up capital of ₹3.75 Lakh. It is led by directors Pooja Vinay Sharma and Ashokkumar Sharma.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop – 25 Angelica Heights Chakradhar Nagarnsp W Nalasopara West, Thane, Maharashtra, India – 401203.
As per the financials filed for FY 2025, the company reported a revenue of ₹6 Lakh, a decline of 43% compared to the previous year. For the same year it recorded a net loss of ₹3,446 (net margin -0.6%) and EBITDA of ₹82,215 (EBITDA margin 13.7%). Revenue has declined at a compounded annual rate (CAGR) of 23% over three years.
As per MCA filings, the company has open charges of ₹7 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop – 25 Angelica Heights Chakradhar Nagarnsp W Nalasopara West, Thane, Maharashtra, India – 401203
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Krishicon Pharmaceuticals Private Limited
The main business activity of Krishicon Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Krishicon Pharmaceuticals Private Limited FY 2025 filings available
Krishicon Pharmaceuticals Private Limited reported revenue of ₹6 Lakh (down 43% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Krishicon Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 23% over three years, including a 43% fall in the latest year. EBITDA rose 173% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Krishicon Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹82,215 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3,446 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Krishicon Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Krishicon Pharmaceuticals are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Krishicon Pharmaceuticals Private Limited
Krishicon Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Octogena Pharmaceuticals Private Limited | ₹6.04 Lakh (FY 2025) | •••• | •••• | -35.0% | •••• | Solapur North, Maharashtra, India |
| Caelum Pharmaceuticals Private Limited | ₹6.01 Lakh (FY 2024) | •••• | •••• | -17.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Rexha Pharmaceuticals Private Limited | ₹6.01 Lakh (FY 2025) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Sandro Bio Pharmaceuticals Private Limited | ₹6.01 Lakh (FY 2025) | •••• | •••• | 6.0% | •••• | Chennai, Tamil Nadu, India |
| Innogent Pharmaceuticals Private Limited | ₹6.01 Lakh (FY 2025) | •••• | •••• | •••• | Navi Mumbai, Maharashtra, India | |
| Krishicon Pharmaceuticals Private Limited this company | ₹6 Lakh (FY 2025) | •••• | •••• | -43.0% | •••• | Thane, Maharashtra, India |
| Novarance Pharmaceuticals Private Limited | ₹6 Lakh (FY 2025) | •••• | •••• | 73.0% | •••• | Mirzapur, Uttar Pradesh, India |
| Felding Roth Pharmaceuticals Private Limited | ₹5.96 Lakh (FY 2025) | •••• | •••• | -13.0% | •••• | Lucknow, Uttar Pradesh, India |
| Zisel Pharmaceuticals Private Limited | ₹5.96 Lakh (FY 2020) | •••• | •••• | 5830.0% | •••• | Varanasi, Uttar Pradesh, India |
| Riedeli Pharmaceuticals Private Limited | ₹5.95 Lakh (FY 2024) | •••• | •••• | -1.0% | •••• | Allahabad, Uttar Pradesh, India |
| Prumed Pharmaceuticals Private Limited | ₹5.94 Lakh (FY 2025) | •••• | •••• | -49.0% | •••• | Saurbazar, Bihar, India |
Peers are the five companies nearest above and the five nearest below Krishicon Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Krishicon Pharmaceuticals Private Limited
Krishicon Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pooja Vinay Sharma | Director | 18 Jun 2022 | 4 Years 3 Months | Current |
| Ashokkumar Sharma | Director | 11 Mar 2024 | 2 Years 7 Months | Current |
Charges & Borrowings of Krishicon Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Mar 2023 | State Bank of India | ₹7 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Krishicon Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Krishicon Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Krishicon Pharmaceuticals Private Limited
Krishicon Pharmaceuticals Private Limited has 7 board changes on record since 2022: 3 appointments and 4 cessations. The latest: Ashokkumar Sharma was appointed as Director on 11 Mar 2024.
Credit Ratings, Litigation & Regulatory Alerts for Krishicon Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Krishicon Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Krishicon Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Krishicon Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Krishicon Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Krishicon Pharmaceuticals Private Limited
Krishicon Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 January 2021 (5+ years old) and is registered under CIN U24100MH2021PTC352896.
Krishicon Pharmaceuticals reported revenue of ₹6 Lakh for FY 2025 (down 43% YoY).
Krishicon Pharmaceuticals has 2 current directors:
- Pooja Vinay Sharma - Director
- Ashokkumar Sharma - Director
Krishicon Pharmaceuticals reported a net loss of ₹3,446 (net margin -0.6%) and EBITDA of ₹82,215 (EBITDA margin 13.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Krishicon Pharmaceuticals is -23% over three years. In the latest year (FY 2025) revenue fell 43%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Krishicon Pharmaceuticals is U24100MH2021PTC352896. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Krishicon Pharmaceuticals was incorporated on 02 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Krishicon Pharmaceuticals by revenue are Octogena Pharmaceuticals Private Limited, Caelum Pharmaceuticals Private Limited, Rexha Pharmaceuticals Private Limited, Sandro Bio Pharmaceuticals Private Limited, Innogent Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Ashokkumar Sharma was appointed as Director on 11 Mar 2024. Vinay Ashok Sharma ceased to be Director on 11 Mar 2024. Pooja Vinay Sharma ceased to be Additional Director on 25 Sep 2022. Krishicon Pharmaceuticals has 7 board changes on record in total.
The registered office of Krishicon Pharmaceuticals is at Shop – 25 Angelica Heights Chakradhar Nagarnsp W Nalasopara West, Thane, Maharashtra, India – 401203.
Krishicon Pharmaceuticals has an authorised share capital of ₹3.75 Lakh and a paid-up capital of ₹3.75 Lakh.